# The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity

> **NCT03741738** · — · COMPLETED · sponsor: **Yonsei University** · enrollment: 43 (actual)

## Conditions studied

- Vitiligo

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03741738
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-30
- **Primary completion:** 2020-06-09
- **Final completion:** 2020-06-09
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03741738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03741738, "The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03741738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*